| Title |
The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, August 2021
|
| DOI | 10.2147/tcrm.s275076 |
| Pubmed ID | |
| Authors |
Manasvi Gupta, Shiavax Rao, Gaurav Manek, Gregg C Fonarow, Raktim K Ghosh |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 16% |
| Other | 4 | 7% |
| Student > Master | 3 | 5% |
| Student > Ph. D. Student | 3 | 5% |
| Unspecified | 2 | 4% |
| Other | 3 | 5% |
| Unknown | 33 | 58% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 16% |
| Biochemistry, Genetics and Molecular Biology | 5 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Nursing and Health Professions | 3 | 5% |
| Unspecified | 2 | 4% |
| Other | 0 | 0% |
| Unknown | 35 | 61% |